A chemiluminescent assay for measuring avermectin binding sites
β Scribed by James M. Schaeffer; Janet H. Stiffey; Helmut Mrozik
- Publisher
- Elsevier Science
- Year
- 1989
- Tongue
- English
- Weight
- 477 KB
- Volume
- 177
- Category
- Article
- ISSN
- 0003-2697
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Tubulin is an attractive and established target for anticancer therapy. To date, the only method to determine the binding of inhibitor to tubulin has been competitive radioligand binding assays. We developed a nonβradioactive mass spectrometry (MS) binding assay to study the tubulin bin
Glycosaminoglycans complex with constituents of normal human serum, a finding that was exploited to develop a competitive binding assay for these substances. Heparan sulfate was isolated from renal cortex and radiolabeled with tritiated borohydride. The elution pattern of the radiolabeled material o
Involvement of coenzyme Q (CoQ) m anti-omdant actiwhes, m ad&bon to Its mayor redox role, has frequently been suggested m recent years In order to eluudate it CoQ could really be engaged m scavengmg free rticals produced endogenously m a blologtcal system, an expenmental system was developed m which